Reciprocal Interaction between Carcinoma-Associated Fibroblasts and Squamous Carcinoma Cells through Interleukin-1α Induces Cancer Progression

Neoplasia (United States)

Volumn 16, Issue 11, 2014, Pages 928-938

  Bae, Jung Yoon ^a   Kim, Eun Kyoung ^a   Yang, Dong Hyun ^a   Zhang, Xianglan ^a   Park, Young Jin ^a   Lee, Doo Young ^a   Che, Chung Min ^a   Kim, Jin ^a  

^a Yonsei University College of Dentistry   (South Korea)

Author keywords

Cancer progression; Carcinoma associated fibroblasts; Interleukin 1 alpha; Oral squamous cell carcinoma; Reciprocal interaction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CXCL1 CHEMOKINE; CYCLINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 3; VIMENTIN; ACTIN; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMA ASSOCIATED FIBROBLAST; CARCINOMA CELL; CELL INTERACTION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL COMMUNICATION; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; WESTERN BLOTTING; XENOGRAFT;

ACTINS; ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FIBROBLASTS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1ALPHA; KAPLAN-MEIER ESTIMATE; MALE; MICE, INBRED BALB C; MOUTH NEOPLASMS; MUSCLE, SMOOTH; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84937565995     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2014.09.003     Document Type: Article

References (48)

1. Oskarsson T., Massague J. Extracellular matrix players in metastatic niches. EMBO J 2012, 31:254-256.
2. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309-322.
3. Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012, 196:395-406.
4. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
5. Allen M., Louise Jones J. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 2011, 223:162-176.
6. Wu S.D., Ma Y.S., Fang Y., Liu L.L., Fu D., Shen X.Z. Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev 2012, 38:218-225.
7. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401.
8. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
9. Schauer I.G., Sood A.K., Mok S., Liu J. Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia 2011, 13:393-405.
10. Haviv I., Polyak K., Qiu W., Hu M., Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle 2009, 8:589-595.
11. Polanska U.M., Orimo A. Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol 2013, 228:1651-1657.
12. Orimo A., Weinberg R.A. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006, 5:1597-1601.
13. Dean J.P., Nelson P.S. Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis. Br J Cancer 2008, 98:245-249.
14. López-Novoa J.M., Nieto M.A. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 2009, 1:303-314.
15. Marsh D., Suchak K., Moutasim K.A., Vallath S., Hopper C., Jerjes W., Upile T., Kalavrezos N., Violette S.M., Weinreb P.H., et al. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol 2011, 223:470-481.
16. Kadaba R., Birke H., Wang J., Hooper S., Andl C.D., Di Maggio F., Soylu E., Ghallab M., Bor D., Froeling F.E., et al. Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes. J Pathol 2013, 230:107-117.
17. Guo M., Liu W., Serra S., Asa S.L., Ezzat S. FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression. Cancer Res 2012, 72:2017-2027.
18. Schauer I.G., Zhang J., Xing Z., Guo X., Mercado-Uribe I., Sood A.K., Huang P., Liu J. Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts. Neoplasia 2013, 15:409-420.
19. Lai K.P., Yamashita S., Huang C.K., Yeh S., Chang C. Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. EMBO Mol Med 2012, 4:791-807.
20. Tjomsland V., Spångeus A., Välilä J., Sandström P., Borch K., Druid H., Falkmer S., Falkmer U., Messmer D., Larsson M. Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts. Neoplasia 2011, 13:664-675.
21. Kogan-Sakin I., Cohen M., Paland N., Madar S., Solomon H., Molchadsky A., Brosh R., Buganim Y., Goldfinger N., Klocker H., et al. Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis 2009, 30:698-705.
22. Jung D.W., Che Z.M., Kim J., Kim K., Kim K.Y., Williams D., Kim J. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int J Cancer 2010, 127:332-344.
23. Ayala G., Tuxhorn J.A., Wheeler T.M., Frolov A., Scardino P.T., Ohori M., Wheeler M., Spitler J., Rowley D.R. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin Cancer Res 2003, 9:4792-4801.
24. Halvorsen T.B., Seim E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol 1989, 42:162-166.
25. Jass J.R., Atkin W.S., Cuzick J., Bussey H.J., Morson B.C., Northover J.M., Todd I.P. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986, 10:437-459.
26. Kawashiri S., Tanaka A., Noguchi N., Hase T., Nakaya H., Ohara T., Kato K., Yamamoto E. Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity. Head Neck 2009, 31:1346-1353.
27. Tsujino T., Seshimo I., Yamamoto H., Ngan C.Y., Ezumi K., Takemasa I., Ikeda M., Sekimoto M., Matsuura N., Monden M. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 2007, 13:2082-2090.
28. Fuyuhiro Y., Yashiro M., Noda S., Matsuoka J., Hasegawa T., Kato Y., Sawada T., Hirakawa K. Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells. Cancer Sci 2012, 103:797-805.
29. Witton C.J., Hawe S.J., Cooke T.G., Bartlett J.M. Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology 2004, 45:47-54.
30. Lee H.Y., Oh S.H., Woo J.K., Kim W.Y., Van Pelt C.S., Price R.E., Cody D., Tran H., Pezzuto J.M., Moriarty R.M., et al. Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. J Natl Cancer Inst 2005, 97:1695-1699.
31. Berridge M.V., Tan A.S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993, 303:474-482.
32. Kim E.J., Che Z.M., Park Y.J., Hwang Y.S., Kim K.Y., Jung da W., Jeon N.K., Choi Y.W., Lee E.J., Kim J. Morphogenesis and biological significance of spindle cell transformation in a spindle cell carcinoma. Cancer Lett 2009, 275:61-71.
33. Namba M., Nishitani K., Fukushima F., Kimoto T., Yuasa Y. Multi-step neoplastic transformation of normal human fibroblasts by Co-60 gamma rays and Ha-ras oncogenes. Mutat Res 1988, 199:415-423.
34. Murata T., Mizushima H., Chinen I., Moribe H., Yagi S., Hoffman R.M., Kimura T., Yoshino K., Ueda Y., Enomoto T., et al. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers. Cancer Res 2011, 71:6633-6642.
35. Davalos A.R., Coppe J.P., Campisi J., Desprez P.Y. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev 2010, 29:273-283.
36. Velarde M.C., Demaria M., Campisi J. Senescent cells and their secretory phenotype as targets for cancer therapy. Interdiscip Top Gerontol 2013, 38:17-27.
37. Bandapalli O.R., Ehrmann F., Ehemann V., Gaida M., Macher-Goeppinger S., Wente M., Schirmacher P., Brand K. Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis. Cytokine 2012, 57:46-53.
38. Bolitho C., Hahn M.A., Baxter R.C., Marsh D.J. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor. Endocr Relat Cancer 2010, 17:929-940.
39. Luppi F., Longo A.M., de Boer W.I., Rabe K.F., Hiemstra P.S. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 2007, 56:25-33.
40. Christofakis E.P., Miyazaki H., Rubink D.S., Yeudall W.A. Roles of CXCL8 in squamous cell carcinoma proliferation and migration. Oral Oncol 2008, 44:920-926.
41. Zhu Y.M., Webster S.J., Flower D., Woll P.J. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 2004, 91:1970-1976.
42. Burgess M., Cheung C., Chambers L., Ravindranath K., Minhas G., Knop L., Mollee P., McMillan N.A., Gill D. CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro. Leuk Lymphoma 2012, 53:1988-1998.
43. Van Sweringen H.L., Sakai N., Tevar A.D., Burns J.M., Edwards M.J., Lentsch A.B. CXC chemokine signaling in the liver: impact on repair and regeneration. Hepatology 2011, 54:1445-1453.
44. Dong Q., Zhang J., Hendricks D.T., Zhao X. GROβ and its downstream effector EGR1 regulate cisplatin-induced apoptosis in WHCO1 cells. Oncol Rep 2011, 25:1031-1037.
45. Kim S.J., Uehara H., Karashima T., McCarty M., Shih N., Fidler I.J. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia 2001, 3:33-42.
46. Fujimoto J., Sakaguchi H., Aoki I., Tamaya T. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 2000, 60:2632-2635.
47. Matsuo Y., Sawai H., Ma J., Xu D., Ochi N., Yasuda A., Takahashi H., Funahashi H., Takeyama H. IL-1α secreted by colon cancer cells enhances angiogenesis: the relationship between IL-1α release and tumor cells' potential for liver metastasis. J Surg Oncol 2009, 99:361-367.
48. Matsuo Y., Sawai H., Ochi N., Yasuda A., Takahashi H., Funahashi H., Takeyama H., Guha S. Interleukin-1alpha secreted by pancreatic cancer cells promotes angiogenesis and its therapeutic implications. J Surg Res 2009, 153:274-281.